In this study, we used CRISPR technology to suppress lncRNA expression and provided several evidences supporting a critical role for lncRNA HOXA-AS3 in tumor-promoting effects by targeting miR-29c/CDK6 axis. Here, PDS5B is linked to neoplasm.